Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$171.04
-0.3%
$177.66
$163.33
$251.99
$49.17B0.252.02 million shs2.12 million shs
GSK PLC Sponsored ADR stock logo
GSK
GSK
$38.27
-1.1%
$38.75
$31.72
$44.67
$79.19B0.524.93 million shs3.83 million shs
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$373.81
-1.4%
$364.79
$289.98
$417.14
$91.18B1.491.47 million shs1.29 million shs
Humana Inc. stock logo
HUM
Humana
$238.69
0.0%
$242.88
$212.45
$406.46
$28.82B0.431.82 million shs1.35 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
-0.34%+1.49%-0.26%-25.23%-26.90%
GSK PLC Sponsored ADR stock logo
GSK
GSK
-1.00%-1.00%-1.10%-0.70%-5.07%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
-1.39%-0.73%-0.81%+9.32%+9.80%
Humana Inc. stock logo
HUM
Humana
+0.03%-2.01%+6.17%-11.61%-32.93%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
4.9599 of 5 stars
4.24.03.34.03.12.51.3
GSK PLC Sponsored ADR stock logo
GSK
GSK
2.3208 of 5 stars
1.14.02.50.02.60.02.5
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
4.889 of 5 stars
2.45.02.54.53.22.52.5
Humana Inc. stock logo
HUM
Humana
4.4923 of 5 stars
3.23.02.53.92.21.71.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.36
Hold$219.2228.17% Upside
GSK PLC Sponsored ADR stock logo
GSK
GSK
2.10
Hold$37.38-2.34% Downside
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2.75
Moderate Buy$394.335.49% Upside
Humana Inc. stock logo
HUM
Humana
2.30
Hold$280.7617.63% Upside

Current Analyst Ratings Breakdown

Latest HCA, HUM, GSK, and BDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/23/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$376.00 ➝ $404.00
6/17/2025
Humana Inc. stock logo
HUM
Humana
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$320.00 ➝ $260.00
6/17/2025
Humana Inc. stock logo
HUM
Humana
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetHold ➝ Hold$305.00 ➝ $280.00
6/12/2025
Humana Inc. stock logo
HUM
Humana
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$273.00 ➝ $268.00
6/9/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetEqual Weight ➝ Equal Weight$355.00 ➝ $410.00
6/3/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$261.00 ➝ $241.00
6/3/2025
GSK PLC Sponsored ADR stock logo
GSK
GSK
Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/2/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$366.00 ➝ $416.00
6/2/2025
Humana Inc. stock logo
HUM
Humana
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$322.00 ➝ $273.00
5/29/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$320.00 ➝ $385.00
(Data available from 6/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$20.87B2.35$21.06 per share8.12$89.57 per share1.91
GSK PLC Sponsored ADR stock logo
GSK
GSK
$40.10B1.95$5.52 per share6.93$8.07 per share4.74
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$70.60B1.27$35.40 per share10.56$2.19 per share170.69
Humana Inc. stock logo
HUM
Humana
$117.76B0.24$23.87 per share10.00$136.57 per share1.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.71B$5.2432.6410.941.307.28%15.99%7.36%8/7/2025 (Estimated)
GSK PLC Sponsored ADR stock logo
GSK
GSK
$3.29B$1.9419.738.231.359.89%48.82%11.15%7/30/2025 (Estimated)
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.76B$22.4916.6213.341.318.07%1,063.91%10.10%7/22/2025 (Estimated)
Humana Inc. stock logo
HUM
Humana
$1.21B$14.1416.8818.181.801.42%14.47%5.03%7/30/2025 (Estimated)

Latest HCA, HUM, GSK, and BDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$6.20N/AN/AN/A$18.49 billionN/A
5/1/2025Q2 2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.28$3.35+$0.07$1.06$5.35 billion$5.27 billion
4/30/2025Q1 2025
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.08$1.13+$0.05$1.00$7.52 billion$10.06 billion
4/30/2025Q1 2025
Humana Inc. stock logo
HUM
Humana
$10.07$11.58+$1.51$10.30$32.00 billion$32.11 billion
4/25/2025Q1 2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$5.75$6.45+$0.70$6.45$18.26 billion$18.32 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.162.43%N/A79.39%53 Years
GSK PLC Sponsored ADR stock logo
GSK
GSK
$1.694.42%N/A87.11%N/A
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
$2.880.77%N/A12.81%6 Years
Humana Inc. stock logo
HUM
Humana
$3.541.48%N/A25.04%N/A

Latest HCA, HUM, GSK, and BDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/17/2025
Humana Inc. stock logo
HUM
Humana
quarterly$0.88501.24%6/27/20256/27/20257/25/2025
5/2/2025
GSK PLC Sponsored ADR stock logo
GSK
GSK
quarterly$0.42164.1%5/16/20255/16/20257/10/2025
4/29/2025
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.042.02%6/9/20256/9/20256/30/2025
4/25/2025
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
quarterly$0.720.84%6/16/20256/16/20256/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.70
1.13
0.64
GSK PLC Sponsored ADR stock logo
GSK
GSK
1.21
0.87
0.58
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
69.07
1.19
1.06
Humana Inc. stock logo
HUM
Humana
0.71
1.91
1.91

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
GSK PLC Sponsored ADR stock logo
GSK
GSK
15.74%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
62.73%
Humana Inc. stock logo
HUM
Humana
92.38%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.36%
GSK PLC Sponsored ADR stock logo
GSK
GSK
10.00%
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1.30%
Humana Inc. stock logo
HUM
Humana
0.37%
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
74,000286.61 million285.58 millionOptionable
GSK PLC Sponsored ADR stock logo
GSK
GSK
68,6292.05 billion1.84 billionOptionable
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
316,000240.57 million237.45 millionOptionable
Humana Inc. stock logo
HUM
Humana
65,680120.69 million120.25 millionOptionable

Recent News About These Companies

Humana: Margin Over Volume Signals A Buy
Invesco LLC Cuts Stock Position in Humana Inc. (NYSE:HUM)
Humana holds investor day on Medicare Advantage
Humana plans to reach 4-star Medicare Advantage ratings in 2028

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$171.04 -0.53 (-0.31%)
Closing price 06/25/2025 03:59 PM Eastern
Extended Trading
$170.88 -0.16 (-0.09%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

GSK stock logo

GSK NYSE:GSK

$38.27 -0.41 (-1.06%)
Closing price 06/25/2025 03:59 PM Eastern
Extended Trading
$38.44 +0.17 (+0.44%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

HCA Healthcare stock logo

HCA Healthcare NYSE:HCA

$373.81 -5.21 (-1.37%)
Closing price 06/25/2025 03:59 PM Eastern
Extended Trading
$373.50 -0.31 (-0.08%)
As of 06/25/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Humana stock logo

Humana NYSE:HUM

$238.69 -0.10 (-0.04%)
Closing price 06/25/2025 03:59 PM Eastern
Extended Trading
$241.20 +2.52 (+1.05%)
As of 06/25/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.